MNBTD
UTHR icon

Moody National Bank Trust Division’s United Therapeutics UTHR Stock Holding History

Moody National Bank Trust Division’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.04M Sell
1,918
-252
-12% -$130K 0.09% 223
2026
Q2 		$1.18M Buy
2,170
+7
+0.3% +$3.94K 0.1% 209
2026
Q1 		$1.28M Buy
2,163
+23
+1% +$11.5K 0.12% 158
2025
Q4 		$1.04M Sell
2,140
-1,248
-37% -$581K 0.1% 208
2025
Q3 		$1.42M Sell
3,388
-81
-2% -$27.2K 0.12% 180
2025
Q2 		$997K Buy
3,469
+77
+2% +$23K 0.09% 240
2025
Q1 		$1.05M Buy
3,392
+11
+0.3% +$3.77K 0.11% 221
2024
Q4 		$1.19M Sell
3,381
-207
-6% -$76.1K 0.12% 190
2024
Q3 		$1.29M Buy
3,588
+97
+3% +$32.8K 0.14% 174
2024
Q2 		$1.11M Buy
3,491
+30
+0.9% +$7.94K 0.09% 169
2024
Q1 		$795K Buy
3,461
+39
+1% +$8.8K 0.06% 232
2023
Q4 		$752K Buy
+3,422
New +$789K 0.06% 251

Other funds holding UTHR

AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
RI
Ridgewood Investments Springfield, New Jersey $271M AUM
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
BTC
Bank & Trust Company Litchfield, Illinois $159M AUM 30.15% 1-Year Est. Return
WWM
Whalen Wealth Management Las Vegas, Nevada $234M AUM 28.06% 1-Year Est. Return
SRS
Strong Retirement Solutions Silverdale, Washington $178M AUM 20.42% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
BONH
Bank of New Hampshire Laconia, New Hampshire $463M AUM 23.57% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Moody National Bank Trust Division's UTHR Position: Q3 2026 in Review

Moody National Bank Trust Division reduced its United Therapeutics (UTHR) stake by 12% in Q3 2026, selling an estimated $130K and leaving 1,918 shares worth $1.04M. The position accounts for 0.09% of the portfolio, ranked #223.

Moody National Bank Trust Division first reported a position in UTHR in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.42M in Q3 2025. 17 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Moody National Bank Trust Division held 1,918 shares of United Therapeutics worth $1.04M as of Q3 2026.
  • Moody National Bank Trust Division sold 252 United Therapeutics shares in Q3 2026, an estimated $130K.
  • United Therapeutics made up 0.09% of Moody National Bank Trust Division's portfolio in Q3 2026, its #223 holding.
  • Moody National Bank Trust Division first reported a position in United Therapeutics in Q4 2023 and has held it in 12 quarters since.
  • Moody National Bank Trust Division's United Therapeutics position peaked at $1.42M in Q3 2025.
  • 17 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Moody National Bank Trust Division's 13F filing for Q3 2026, filed 6 Oct 2026.